Telemedicine's value is clear, but future growth needs clarity around standards and practices
Literature survey from Altarum Institute finds a growing body of evidence of value
Intelligent Hospital Systems buys AmerisourceBergen unit, shaking up pharmacy-automation field
IHS, hereafter to be known as ARxIUM, will expand its injectable-compounding business to include oral solids
Politics and drugs
Medical marijuana and biosimilars are two topics where 'the will of the people' push decisions
A conversation with W. Scott Evangelista, Quintiles
Manufacturers: Get ready for global trade account management
Partnering to diversify yields rapid growth
A family-owned pharmaceutical manufacturer plots a 21st-century growth plan
Purdue Pharma exec and Cardinal Health win HDMA distribution awards
AmerisourceBergen-Walgreens Alliance Boots, and H. D. Smith-Legisym are runners-up
Campbell Alliance updates, expands its commercial launch consulting services
More executional capabilities derive from affiliation with parent, inVentiv Health
HealthPrize touts its success with 'gamification' in adherence programs
Company uses online media to promote fill rates by more than 50%
Exostar grows its network of collaborative tools in life sciences
Identity Hub expedites access to regulated content in prescribing and other commercial applications
Symphony Health Solutions builds a 5-million-patient, longitudinal cardiovascular registry
Collaboration with American College of Cardiology could result in new health-outcomes results
Rite Aid to buy EnvisionRx, continuing a reshaping of US drug distribution
$2-billion acquisition brings a $5-billion/yr PBM to Rite Aid's 4,600 retail stores
Independent physicians and their clinics remain a dominant channel for specialty distribution, says HDMA
Association's annual specialty-distribution study focuses trend in oncology, chronic diseases
Preventing and Managing Drug Shortages--PDA Technical Report 68
The Parenteral Drug Association offers risk management guidance*
'Capacity crunch' is the theme of HPCLC meeting
2015 spring meeting focuses on meeting transportation bottlenecks
Alliance Life Sciences partners with Revitas to better manage pharma revenue practices
1.5-10% improvement in 'revenue capture' is possible
Next agg-spend deadline looms with little buzz from industry
Reporting by pharma companies on spending on physicians is becoming a non-event
The biosimilars payoff in the US might be small and fleeting
Analysis from Prime Therapeutics points to severe cost hurdles for biosimilars developed and marketed in the US
Bayer upgrades temperature-controlled packaging and saves money while doing so
New design from Emball'Iso triples payload capacity
Medical marijuana looks for a place in conventional drug distribution
It's still early days in making medical marijuana--and cannabis-based pharmaceuticals--part of normal dispensing
Cloud-based services manage regulated content better
Unifying the management of clinical research documentation and marketing content saves time and accelerates speed-to-therapy
Advances in cold chain packaging
GDP standards drive higher performance standards for packaging
ACOs raise the stakes for evidence-based medicine
Manufacturers will need to refine their interactions with healthcare providers and produce better outcomes research and adherence programs to compete
Pharmaceutical cold chain logistics is a $10-billion global industry
Pharmaceutical Commerce's annual Cold Chain Sourcebook projects 44% growth over the 2013-2019 span
FDA approves first biosimilar--but don't look for it on pharmacy shelves yet
'Filgrastim-sndz' is Sandoz' Zarxio, the biosimilar of Amgen's Neuprogen
TraceLink relocates to new offices as employment more than doubles
Success in managing DSCSA traceability requirements bring a $20-million equity investment
Next agg-spend reporting deadline looms with little buzz from industry
Healthcare providers continue to criticize Genentech's limited-distribution action
Last year's decision will cost US hospitals $300 million, says Novation-led group
Cardinal Health will acquire J&J's Cordis for $1.94 billion
Emphasis of 'physician preference items' in healthcare distribution
